Oncology & Cancer

Innovative computational approach yields novel cancer targets

Researchers at Weill Cornell Medicine have used artificial intelligence to identify drug targets based on mapping regulatory networks in patient tumors. The study, published in Cell Systems, experimentally identified and ...

Health informatics

Researchers explore potential for AI in biomedical science

Generative artificial intelligence (AI) powered by human language has made remarkable progress and gained widespread use through tools such as ChatGPT. While it is mostly known for helping with reading and writing, scientists ...

Oncology & Cancer

Engineered DNA 'warhead' targets a common cancer mutation

Tumor protein P53 (TP53) plays an important role in suppressing the growth of tumors. Mutations in the gene for TP53 can have a disastrous effect, hampering the body's ability to fight tumors and even encouraging their growth. ...

page 1 from 29